Navidea Biopharmaceuticals Inc (OTCPK:NAVB)
$ 0.0001 0 (0%) Market Cap: 10,000.00 Enterprise Value: -2.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2020 Navidea Biopharmaceuticals Inc Earnings Call Transcript

Nov 12, 2020 / 10:00PM GMT
Release Date Price: $2.24 (-0.44%)
Operator

Greetings, and thank you for standing by, and welcome to the Navidea Biopharmaceuticals Q3 2020 Earnings and Business Call. (Operator Instructions) This conference is being recorded, Thursday, November 12, 2020.

And now I'd like to turn the conference over to Jed Latkin, CEO, COO and CFO. Please go ahead.

Jed A. Latkin
Navidea Biopharmaceuticals, Inc. - CEO, COO, CFO & Director

Thank you, Scott. This call is -- first off, I just want to start with us saying that this call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following the prepared remarks here, we're just going to do a Q&A as well, as always.

During the course of the conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data readouts, along with capital resources and strategic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot